Clinical Team Leader
Therakos LLC · Daiichi Sankyo · Stratatech, a Mallinckrodt Company
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
25
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Clinical Team Leader as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06646016 · EPIC- Extracorporeal Photopheresis (ECP) for Immune-related ColitisTherakos LLC · withdrawn · Immune-related Colitis · study director
- N/ANCT05769751 · A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast CancerDaiichi Sankyo · completed · HER2-positive Breast Cancer · study director
- Ph3NCT05517902 · StrataGraft Safety, Tolerability and Efficacy in Pediatric SubjectsStratatech, a Mallinckrodt Company · completed · Skin Wound, Burns, Trauma-related Wound · study director
- Ph1/Ph2NCT04765202 · StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal BurnsStratatech, a Mallinckrodt Company · terminated · Full Thickness Thermal Burn · study director
- Ph4NCT04526704 · Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With PexidartinibDaiichi Sankyo · completed · Tenosynovial Giant Cell Tumor · study director
- Ph3NCT04128462 · MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain FunctionMallinckrodt · withdrawn · Hepatic Encephalopathy · study director
- Ph1NCT03846843 · OCR002-SP103 - Oral Immediate Release StudyOcera Therapeutics, Inc. · completed · Cirrhosis · study director
- Ph2NCT03712280 · MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)Mallinckrodt · completed · Hepatic Cirrhosis, Hepatic Encephalopathy (HE) · study director
- Ph1NCT03552029 · Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)Daiichi Sankyo · terminated · Acute Myeloid Leukemia · study director
- Ph4NCT03320070 · Acthar Gel in Participants With Pulmonary SarcoidosisMallinckrodt · completed · Sarcoidosis, Pulmonary · study director
- N/ANCT03132428 · Registry to Evaluate INOmax in Newborn Babies With Pulmonary HypertensionMallinckrodt · terminated · Pulmonary Hypertension of Newborn · study director
- Ph4NCT03126760 · Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)Mallinckrodt ARD LLC · terminated · Multiple Sclerosis, Relapsing-Remitting · study director
- Ph2/Ph3NCT03068754 · Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)Mallinckrodt · terminated · Amyotrophic Lateral Sclerosis · study director
- Ph3NCT03005106 · StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal ElementsStratatech, a Mallinckrodt Company · completed · Burn, Thermal · study director
- Ph4NCT02919761 · Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisMallinckrodt · completed · Arthritis, Rheumatoid · study director
- Ph3NCT02766777 · Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional ConstipationSucampo Pharma Americas, LLC · completed · Constipation - Functional · study director
- Ph4NCT02633046 · Acthar for Treatment-Resistant or Treatment-Intolerant ProteinuriaMallinckrodt ARD LLC · completed · Idiopathic Focal Segmental Glomerulosclerosis · study director
- Ph3NCT02524847 · Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host DiseaseTherakos, Inc., a Mallinckrodt Company · terminated · Steroid Refractory Acute Graft Versus Host Disease · study director
- Ph3NCT02042183 · Lubiprostone in Children With Functional ConstipationSucampo Pharma Americas, LLC · completed · Constipation - Functional · study director
- Ph2NCT01966419 · Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)Ocera Therapeutics, Inc. · completed · Acute Episode of Overt Hepatic Encephalopathy, Hepatic Encephalopathy · study chair
- Ph3NCT01635101 · A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric PatientsMallinckrodt · completed · Acute Pain · study director
- Ph3NCT01143246 · A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With TerlipressinMallinckrodt · completed · Hepatorenal Syndrome · study director
- Ph2NCT00850993 · A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaInfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · terminated · Hyperbilirubinemia, Neonatal · study director
- Ph3NCT00595946 · Opioid-induced Bowel Dysfunction: Pivotal Assessment of LubiprostoneSucampo Pharma Americas, LLC · completed · Opioid-Induced Bowel Dysfunction · study director
- Ph3NCT00551642 · Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature BabiesMallinckrodt · completed · Lung Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.